{"parse":{"title":"PASLI disease","pageid":42008669,"revid":841412906,"text":{"*":"<div class=\"mw-parser-output\"><table class=\"plainlinks metadata ambox ambox-style ambox-Orphan\" role=\"presentation\" style=\"display: none\"><tbody><tr><td class=\"mbox-image\"><div style=\"width:52px\"><a href=\"/wiki/File:Wiki_letter_w.svg\" class=\"image\"><img alt=\"Wiki letter w.svg\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/6/6c/Wiki_letter_w.svg/40px-Wiki_letter_w.svg.png\" width=\"40\" height=\"40\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/6/6c/Wiki_letter_w.svg/60px-Wiki_letter_w.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/6/6c/Wiki_letter_w.svg/80px-Wiki_letter_w.svg.png 2x\" data-file-width=\"44\" data-file-height=\"44\" /></a></div></td><td class=\"mbox-text\"><div class=\"mbox-text-span\">This article <b>is an <a href=\"/wiki/Wikipedia:Orphan\" title=\"Wikipedia:Orphan\">orphan</a>, as no other articles <a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Special:Whatlinkshere&amp;target=PASLI_disease&amp;namespace=0\">link to it</a></b>. Please <a href=\"/wiki/Help:Link\" title=\"Help:Link\">introduce links</a> to this page from <span class=\"plainlinks\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Special%3ASearch&amp;redirs=1&amp;search=PASLI+disease&amp;fulltext=Search&amp;ns0=1&amp;title=Special%3ASearch&amp;advanced=1&amp;fulltext=PASLI+disease\">related articles</a></span>; try the <a rel=\"nofollow\" class=\"external text\" href=\"//edwardbetts.com/find_link?q=PASLI_disease\">Find link tool</a> for suggestions.  <small><i>(February 2014)</i></small></div></td></tr></tbody></table>\n<table class=\"infobox\" style=\"width:22em\"><tbody><tr><th colspan=\"2\" style=\"text-align:center;font-size:125%;font-weight:bold;background:#ccc\">PASLI Disease</th></tr><tr><th colspan=\"2\" style=\"text-align:center;background:#eee;;\">Classification and external resources</th></tr><tr><th scope=\"row\"><a href=\"/wiki/OMIM\" class=\"mw-redirect\" title=\"OMIM\">OMIM</a></th><td>\n<a rel=\"nofollow\" class=\"external text\" href=\"https://omim.org/entry/615513,\">616005 615513, 616005</a></td></tr><tr class=\"noprint\"><td colspan=\"2\" style=\"text-align:center\">\n<div style=\"text-align: right; font-size:0.9em;\">[<a href=\"https://www.wikidata.org/wiki/Q17152451\" class=\"extiw\" title=\"d:Q17152451\">edit on Wikidata</a>]</div></td></tr></tbody></table>\n<p><b>PASLI disease</b> is a rare <a href=\"/wiki/Genetic_disorder\" title=\"Genetic disorder\">genetic disorder</a> of the <a href=\"/wiki/Immune_system\" title=\"Immune system\">immune system</a>.  PASLI stands for \u201cp110 delta activating <a href=\"/wiki/Mutation\" title=\"Mutation\">mutation</a> causing senescent <a href=\"/wiki/T_cells\" class=\"mw-redirect\" title=\"T cells\">T cells</a>, <a href=\"/wiki/Lymphadenopathy\" title=\"Lymphadenopathy\">lymphadenopathy</a>, and <a href=\"/wiki/Immunodeficiency\" title=\"Immunodeficiency\">immunodeficiency</a>.\u201d  The immunodeficiency manifests as recurrent infections usually starting in childhood.  These include bacterial infections of the <a href=\"/wiki/Respiratory_system\" title=\"Respiratory system\">respiratory system</a> and chronic <a href=\"/wiki/Viremia\" title=\"Viremia\">viremia</a> due to <a href=\"/wiki/Epstein-Barr_virus\" class=\"mw-redirect\" title=\"Epstein-Barr virus\">Epstein-Barr virus</a> (EBV) and/or <a href=\"/wiki/Cytomegalovirus\" title=\"Cytomegalovirus\">cytomegalovirus</a> (CMV).  Individuals with PASLI disease also have an increased risk of EBV-associated <a href=\"/wiki/Lymphoma\" title=\"Lymphoma\">lymphoma</a>.  Investigators Carrie Lucas, Michael Lenardo, and Gulbu Uzel at the <a href=\"/wiki/National_Institute_of_Allergy_and_Infectious_Diseases\" title=\"National Institute of Allergy and Infectious Diseases\">National Institute of Allergy and Infectious Diseases</a> at the U.S. <a href=\"/wiki/National_Institutes_of_Health\" title=\"National Institutes of Health\">National Institutes of Health</a> and Sergey Nejentsev at the <a href=\"/wiki/University_of_Cambridge\" title=\"University of Cambridge\">University of Cambridge</a>, UK simultaneously described a mutation causing this condition which they called <a href=\"/wiki/Activated_PI3K_Delta_Syndrome\" class=\"mw-redirect\" title=\"Activated PI3K Delta Syndrome\">Activated PI3K Delta Syndrome</a> (APDS).<sup id=\"cite_ref-Lucas_2014_1-0\" class=\"reference\"><a href=\"#cite_note-Lucas_2014-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-Angulo_2013_2-0\" class=\"reference\"><a href=\"#cite_note-Angulo_2013-2\">&#91;2&#93;</a></sup>\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Signs_and_symptoms\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Signs and symptoms</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Genetics\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Genetics</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-3\"><a href=\"#Inheritance\"><span class=\"tocnumber\">2.1</span> <span class=\"toctext\">Inheritance</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#Diagnosis\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Diagnosis</span></a></li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#Treatment\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Treatment</span></a></li>\n<li class=\"toclevel-1 tocsection-6\"><a href=\"#References\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">References</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Signs_and_symptoms\">Signs and symptoms</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=PASLI_disease&amp;action=edit&amp;section=1\" title=\"Edit section: Signs and symptoms\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:402px;\"><a href=\"/wiki/File:Proposed_model_for_the_effects_of_activating_substitutions_in_p110%CE%B4.png\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/69/Proposed_model_for_the_effects_of_activating_substitutions_in_p110%CE%B4.png/400px-Proposed_model_for_the_effects_of_activating_substitutions_in_p110%CE%B4.png\" width=\"400\" height=\"354\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/69/Proposed_model_for_the_effects_of_activating_substitutions_in_p110%CE%B4.png/600px-Proposed_model_for_the_effects_of_activating_substitutions_in_p110%CE%B4.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/69/Proposed_model_for_the_effects_of_activating_substitutions_in_p110%CE%B4.png/800px-Proposed_model_for_the_effects_of_activating_substitutions_in_p110%CE%B4.png 2x\" data-file-width=\"958\" data-file-height=\"847\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Proposed_model_for_the_effects_of_activating_substitutions_in_p110%CE%B4.png\" class=\"internal\" title=\"Enlarge\"></a></div>Figure 2: Proposed model for the effects of activating substitutions (red asterisk) in p110\u03b4 <sup id=\"cite_ref-Lucas_2014_1-1\" class=\"reference\"><a href=\"#cite_note-Lucas_2014-1\">&#91;1&#93;</a></sup></div></div></div>\n<p>Clinically, PASLI disease is characterized by recurrent <a rel=\"nofollow\" class=\"external text\" href=\"http://www.merriam-webster.com/medical/sinopulmonary\">sinopulmonary</a> infections that can lead to progressive airway damage. Patients also suffer from <a href=\"/wiki/Lymphoproliferative_disorders\" title=\"Lymphoproliferative disorders\">lymphoproliferation</a> (large lymph nodes and spleen), chronic viremia due to EBV or CMV, distinctive lymphoid nodules at mucosal surfaces, autoimmune <a href=\"/wiki/Cytopenias\" class=\"mw-redirect\" title=\"Cytopenias\">cytopenias</a>, and EBV-driven B cell <a href=\"/wiki/Lymphoma\" title=\"Lymphoma\">lymphoma</a>. Importantly, the clinical presentations and disease courses are variable with some individuals severely affected, whereas others show little manifestation of disease.  This \u201c<a href=\"/wiki/Expressivity_(genetics)\" title=\"Expressivity (genetics)\">variable expressivity</a>,\u201d even within the same family, can be striking and may be explained by differences in lifestyle, exposure to <a href=\"/wiki/Pathogens\" class=\"mw-redirect\" title=\"Pathogens\">pathogens</a>, treatment efficacy, or other genetic modifiers.<sup id=\"cite_ref-Lucas_2014_1-2\" class=\"reference\"><a href=\"#cite_note-Lucas_2014-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-Angulo_2013_2-1\" class=\"reference\"><a href=\"#cite_note-Angulo_2013-2\">&#91;2&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Genetics\">Genetics</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=PASLI_disease&amp;action=edit&amp;section=2\" title=\"Edit section: Genetics\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>PASLI disease is caused by <a href=\"/wiki/Mutations\" class=\"mw-redirect\" title=\"Mutations\">gain-of-function mutations</a> in the gene <i><a href=\"/wiki/PIK3CD\" class=\"mw-redirect\" title=\"PIK3CD\">PIK3CD</a></i>, which stands for <a href=\"/wiki/Phosphatidylinositol\" title=\"Phosphatidylinositol\">phosphatidylinositol</a> 3-kinase, <a href=\"/wiki/Catalytic\" class=\"mw-redirect\" title=\"Catalytic\">catalytic</a>, delta.<sup id=\"cite_ref-OMIM_3-0\" class=\"reference\"><a href=\"#cite_note-OMIM-3\">&#91;3&#93;</a></sup>   <i>PIK3CD</i> maps to human <a href=\"/wiki/Chromosome_1\" title=\"Chromosome 1\">chromosome 1p</a>36.2 <sup id=\"cite_ref-Seki_1997_4-0\" class=\"reference\"><a href=\"#cite_note-Seki_1997-4\">&#91;4&#93;</a></sup>  and encodes the <a href=\"/wiki/P110%CE%B4\" title=\"P110\u03b4\">p110\u03b4</a> catalytic PI(3)K subunit.   The p110\u03b4 subunit is a protein of 1,044 <a href=\"/wiki/Amino_acids\" class=\"mw-redirect\" title=\"Amino acids\">amino acids</a> that is predominantly expressed in <a href=\"/wiki/Leukocytes\" class=\"mw-redirect\" title=\"Leukocytes\">leukocytes</a> and plays a role in <a href=\"/wiki/Adaptive_immunity\" class=\"mw-redirect\" title=\"Adaptive immunity\">adaptive immunity</a>. PI(3)K <a href=\"/wiki/Enzymes\" class=\"mw-redirect\" title=\"Enzymes\">enzymes</a> are activated by a variety of <a href=\"/wiki/Cell_surface_receptors\" class=\"mw-redirect\" title=\"Cell surface receptors\">cell surface receptors</a> including antigen receptors on lymphocytes. Once activated, they <a href=\"/wiki/Phosphorylate\" class=\"mw-redirect\" title=\"Phosphorylate\">phosphorylate</a> inositol lipids in the <a href=\"/wiki/Cell_membrane\" title=\"Cell membrane\">cell membrane</a>, which triggers additional downstream signaling events.\n</p><p>A variant of PASLI disease can all be caused by heterozygous <a href=\"/wiki/Splice_site\" class=\"mw-redirect\" title=\"Splice site\">splice site</a> mutation in <a href=\"/wiki/PIK3R1\" title=\"PIK3R1\">PIK3R1</a>, which encodes the <a href=\"/wiki/P85%CE%B1\" class=\"mw-redirect\" title=\"P85\u03b1\">p85\u03b1</a>, p55\u03b1, and p50\u03b1 <a href=\"/wiki/Regulatory\" class=\"mw-redirect\" title=\"Regulatory\">regulatory</a> PI3K subunits. These patients suffer from recurrent sinopulmonary <a href=\"/wiki/Infections\" class=\"mw-redirect\" title=\"Infections\">infections</a> and lymphoproliferation, exhibit hyperactive PI3K <a href=\"/wiki/Cell_signaling\" title=\"Cell signaling\">signaling</a>, and have prominent expansion and skewing of peripheral blood CD8+ <a href=\"/wiki/T_cells\" class=\"mw-redirect\" title=\"T cells\">T cells</a> toward terminally differentiated, <a href=\"/wiki/Senescent\" class=\"mw-redirect\" title=\"Senescent\">senescent</a> effector cells with short <a href=\"/wiki/Telomeres\" class=\"mw-redirect\" title=\"Telomeres\">telomeres</a>.<sup id=\"cite_ref-5\" class=\"reference\"><a href=\"#cite_note-5\">&#91;5&#93;</a></sup>\n</p>\n<div class=\"center\"><div class=\"thumb tnone\"><div class=\"thumbinner\" style=\"width:898px;\"><a href=\"/wiki/File:Protein_domains_of_p110delta.png\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/c/c0/Protein_domains_of_p110delta.png\" width=\"896\" height=\"162\" class=\"thumbimage\" data-file-width=\"896\" data-file-height=\"162\" /></a>  <div class=\"thumbcaption\">Figure 1: p110\u03b4 protein domains; vertical red lines indicate positions of substitution mutations. ABD, adaptor-binding domain; RDB, Ras-binding domain.<sup id=\"cite_ref-Lucas_2014_1-3\" class=\"reference\"><a href=\"#cite_note-Lucas_2014-1\">&#91;1&#93;</a></sup></div></div></div></div>\n<p>P110\u03b4 contains at least five <a href=\"/wiki/Protein_domain\" title=\"Protein domain\">domains</a> (figure 1): adaptor-binding domain, a Ras <a href=\"/wiki/GTPase\" title=\"GTPase\">GTPase</a>-binding domain, a PI(3)K-type C2 domain, helical domain, and a kinase domain.<sup id=\"cite_ref-Lucas_2014_1-4\" class=\"reference\"><a href=\"#cite_note-Lucas_2014-1\">&#91;1&#93;</a></sup>  Mutations have been identified in multiple domains,<sup id=\"cite_ref-Lucas_2014_1-5\" class=\"reference\"><a href=\"#cite_note-Lucas_2014-1\">&#91;1&#93;</a></sup> although there seems to be a recurrent transition mutation (G&gt;A causing E1021K) in the C lobe of the kinase domain,<sup id=\"cite_ref-Lucas_2014_1-6\" class=\"reference\"><a href=\"#cite_note-Lucas_2014-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-Angulo_2013_2-2\" class=\"reference\"><a href=\"#cite_note-Angulo_2013-2\">&#91;2&#93;</a></sup> leading to constitutive activation of enzyme function.  Specific p110\u03b4 mutants cause stronger binding to membranes and relieve inhibition of the kinase by regulatory proteins.<sup id=\"cite_ref-Lucas_2014_1-7\" class=\"reference\"><a href=\"#cite_note-Lucas_2014-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-Angulo_2013_2-3\" class=\"reference\"><a href=\"#cite_note-Angulo_2013-2\">&#91;2&#93;</a></sup>  These changes appear to affect the immune system through over activating the downstream mTOR pathway.<sup id=\"cite_ref-Lucas_2014_1-8\" class=\"reference\"><a href=\"#cite_note-Lucas_2014-1\">&#91;1&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Inheritance\">Inheritance</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=PASLI_disease&amp;action=edit&amp;section=3\" title=\"Edit section: Inheritance\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>PASLI disease is inherited in an <a href=\"/wiki/Autosomal_dominant\" class=\"mw-redirect\" title=\"Autosomal dominant\">autosomal dominant</a> manner.  This means one only needs a single abnormal gene from his/her parents to have PASLI disease.  Of the two copies of <i>PIK3CD</i> each person carries, the abnormal <i>PIK3CD</i> gene dominates despite the fact that the matching <i>PIK3CD</i> gene from the other parent is normal.  Additionally, dominant inheritance means most families with PASLI disease have affected relatives in each generation on the side of the family with the mutation.  An alternative type of <i>PIK3CD</i> mutation is called <i><a href=\"/wiki/De_novo_mutation\" class=\"mw-redirect\" title=\"De novo mutation\">de novo</a></i>, which means that the mutation was not inherited from the parents but rather spontaneously arose in the patient.\n</p><p>Children of a parent who carries a <i>PIK3CD</i> mutation have a 50% chance of inheriting the mutation.  In a family, each child\u2019s risk of inheriting the mutated <i>PIK3CD</i> gene is <a href=\"/wiki/Random_assortment\" class=\"mw-redirect\" title=\"Random assortment\">independent</a> of whether or not other siblings have the mutation. For example, if the first three children in a family have the mutation, the next child has the same 50% risk of inheriting the mutation. Children who do not inherit the abnormal gene will not develop PASLI disease or pass on the mutation.\n</p><p>The variant of PASLI disease due to mutations in <a href=\"/wiki/PIK3R1\" title=\"PIK3R1\">PIK3R1</a> is also inherited in an <a href=\"/wiki/Autosomal_dominant\" class=\"mw-redirect\" title=\"Autosomal dominant\">autosomal dominant</a> manner.\n</p>\n<h2><span class=\"mw-headline\" id=\"Diagnosis\">Diagnosis</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=PASLI_disease&amp;action=edit&amp;section=4\" title=\"Edit section: Diagnosis\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The clinical symptoms are caused by immunological abnormalities (figure 2).  These include deficiency in CD27+ B memory cells, overrepresentation of CD10+ <a href=\"/wiki/Transitional_B_cells\" class=\"mw-redirect\" title=\"Transitional B cells\">transitional B cells</a>, expanded effector (CCR7-) T cells, expanded CD57+ senescent CD8+ T cells, and alterations in serum <a href=\"/wiki/Immunoglobulin\" class=\"mw-redirect\" title=\"Immunoglobulin\">immunoglobulin</a> concentrations, most with normal to elevated concentrations of <a href=\"/wiki/IgM\" class=\"mw-redirect\" title=\"IgM\">IgM</a> and reduced concentrations of <a href=\"/wiki/IgA\" class=\"mw-redirect\" title=\"IgA\">IgA</a>.<sup id=\"cite_ref-Lucas_2014_1-9\" class=\"reference\"><a href=\"#cite_note-Lucas_2014-1\">&#91;1&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Treatment\">Treatment</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=PASLI_disease&amp;action=edit&amp;section=5\" title=\"Edit section: Treatment\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Once a diagnosis is made, the treatment is based on an individual\u2019s clinical condition.  Based on the apparent activation of the <a href=\"/wiki/MTOR_pathway\" class=\"mw-redirect\" title=\"MTOR pathway\">mTOR pathway</a>, Lucas and colleagues <sup id=\"cite_ref-Lucas_2014_1-10\" class=\"reference\"><a href=\"#cite_note-Lucas_2014-1\">&#91;1&#93;</a></sup>  treated patients with <a href=\"/wiki/Rapamycin\" class=\"mw-redirect\" title=\"Rapamycin\">rapamycin</a>, an mTOR inhibitor.  This effectively reduced <a href=\"/wiki/Hepatosplenomegaly\" title=\"Hepatosplenomegaly\">hepatosplenomegaly</a> and <a href=\"/wiki/Lymphadenopathy\" title=\"Lymphadenopathy\">lymphadenopathy</a>, most likely by restoring the normal balance of na\u00efve, effector, and memory cells in the patients\u2019 immune system. More research is needed to determine the most effective timing and dosage of this medication and to investigate other treatment options.  Investigators at the National Institute of Allergy and Infectious Diseases at the US National Institutes of Health currently have clinical protocols to study new approaches to the diagnosis and treatment of this disorder.<sup id=\"cite_ref-6\" class=\"reference\"><a href=\"#cite_note-6\">&#91;6&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=PASLI_disease&amp;action=edit&amp;section=6\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"mw-references-wrap\"><ol class=\"references\">\n<li id=\"cite_note-Lucas_2014-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Lucas_2014_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Lucas_2014_1-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Lucas_2014_1-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Lucas_2014_1-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-Lucas_2014_1-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-Lucas_2014_1-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-Lucas_2014_1-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-Lucas_2014_1-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-Lucas_2014_1-8\"><sup><i><b>i</b></i></sup></a> <a href=\"#cite_ref-Lucas_2014_1-9\"><sup><i><b>j</b></i></sup></a> <a href=\"#cite_ref-Lucas_2014_1-10\"><sup><i><b>k</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Lucas CL, Kuehn HS, Zhao F, Niemela JE, Deenick EK, Palendira U, Avery DT, Moens L, Cannons JL, Biancalana M, Stoddard J, Ouyang W, Frucht DM, Rao VK, Atkinson TP, Agharahimi A, Hussey AA, Folio LR, Olivier KN, Fleisher TA, Pittaluga S, Holland SM, Cohen JI, Oliveira JB, Tangye SG, Schwartzberg PL, Lenardo MJ, Uzel G (2014). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4209962\">\"Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110\u03b4 result in T cell senescence and human immunodeficiency\"</a>. <i>Nature Immunology</i>. <b>15</b> (1): 88\u201397. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/ni.2771\">10.1038/ni.2771</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4209962\">4209962</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24165795\">24165795</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Immunology&amp;rft.atitle=Dominant-activating+germline+mutations+in+the+gene+encoding+the+PI%283%29K+catalytic+subunit+p110%CE%B4+result+in+T+cell+senescence+and+human+immunodeficiency&amp;rft.volume=15&amp;rft.issue=1&amp;rft.pages=88-97&amp;rft.date=2014&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4209962&amp;rft_id=info%3Apmid%2F24165795&amp;rft_id=info%3Adoi%2F10.1038%2Fni.2771&amp;rft.aulast=Lucas&amp;rft.aufirst=CL&amp;rft.au=Kuehn%2C+HS&amp;rft.au=Zhao%2C+F&amp;rft.au=Niemela%2C+JE&amp;rft.au=Deenick%2C+EK&amp;rft.au=Palendira%2C+U&amp;rft.au=Avery%2C+DT&amp;rft.au=Moens%2C+L&amp;rft.au=Cannons%2C+JL&amp;rft.au=Biancalana%2C+M&amp;rft.au=Stoddard%2C+J&amp;rft.au=Ouyang%2C+W&amp;rft.au=Frucht%2C+DM&amp;rft.au=Rao%2C+VK&amp;rft.au=Atkinson%2C+TP&amp;rft.au=Agharahimi%2C+A&amp;rft.au=Hussey%2C+AA&amp;rft.au=Folio%2C+LR&amp;rft.au=Olivier%2C+KN&amp;rft.au=Fleisher%2C+TA&amp;rft.au=Pittaluga%2C+S&amp;rft.au=Holland%2C+SM&amp;rft.au=Cohen%2C+JI&amp;rft.au=Oliveira%2C+JB&amp;rft.au=Tangye%2C+SG&amp;rft.au=Schwartzberg%2C+PL&amp;rft.au=Lenardo%2C+MJ&amp;rft.au=Uzel%2C+G&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4209962&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APASLI+disease\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Angulo_2013-2\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Angulo_2013_2-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Angulo_2013_2-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Angulo_2013_2-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Angulo_2013_2-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Angulo I, Vadas O, Garcon F, Banham-Hall E, Plagnol V, Leahy TR, Baxendale H, Coulter T, Curtis J, Wu C, Blake-Palmer K, Perisic O, Smyth D, Maes M, Fiddler C, Juss J, Cilliers D, Markeli G, Chandra A, Farmer G, Kielkowska A, Clark J, Kracker S, Debr\u00e9 M, Picard C, Pellier I, Jabado N, Morris JA, Barcenas-Morales G, Fischer A, Spehens L, Hawkins P, Barrett JC, Abinum M, Clatworthy M, Durandy A, Doffinger R, Chilvers ER, Cant AJ, Kumararatne D, Okkenhaug K, Williams RL, Condliffe A, Nejentsev S (2013). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3930011\">\"Phosphoinositide 3-kinase \u03b4 gene mutation predisposes to respiratory infection and airway damage\"</a>. <i>Science</i>. <b>342</b> (6160): 866\u2013871. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1126/science.1243292\">10.1126/science.1243292</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3930011\">3930011</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24136356\">24136356</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Phosphoinositide+3-kinase+%CE%B4+gene+mutation+predisposes+to+respiratory+infection+and+airway+damage&amp;rft.volume=342&amp;rft.issue=6160&amp;rft.pages=866-871&amp;rft.date=2013&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3930011&amp;rft_id=info%3Apmid%2F24136356&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.1243292&amp;rft.aulast=Angulo&amp;rft.aufirst=I&amp;rft.au=Vadas%2C+O&amp;rft.au=Garcon%2C+F&amp;rft.au=Banham-Hall%2C+E&amp;rft.au=Plagnol%2C+V&amp;rft.au=Leahy%2C+TR&amp;rft.au=Baxendale%2C+H&amp;rft.au=Coulter%2C+T&amp;rft.au=Curtis%2C+J&amp;rft.au=Wu%2C+C&amp;rft.au=Blake-Palmer%2C+K&amp;rft.au=Perisic%2C+O&amp;rft.au=Smyth%2C+D&amp;rft.au=Maes%2C+M&amp;rft.au=Fiddler%2C+C&amp;rft.au=Juss%2C+J&amp;rft.au=Cilliers%2C+D&amp;rft.au=Markeli%2C+G&amp;rft.au=Chandra%2C+A&amp;rft.au=Farmer%2C+G&amp;rft.au=Kielkowska%2C+A&amp;rft.au=Clark%2C+J&amp;rft.au=Kracker%2C+S&amp;rft.au=Debr%C3%A9%2C+M&amp;rft.au=Picard%2C+C&amp;rft.au=Pellier%2C+I&amp;rft.au=Jabado%2C+N&amp;rft.au=Morris%2C+JA&amp;rft.au=Barcenas-Morales%2C+G&amp;rft.au=Fischer%2C+A&amp;rft.au=Spehens%2C+L&amp;rft.au=Hawkins%2C+P&amp;rft.au=Barrett%2C+JC&amp;rft.au=Abinum%2C+M&amp;rft.au=Clatworthy%2C+M&amp;rft.au=Durandy%2C+A&amp;rft.au=Doffinger%2C+R&amp;rft.au=Chilvers%2C+ER&amp;rft.au=Cant%2C+AJ&amp;rft.au=Kumararatne%2C+D&amp;rft.au=Okkenhaug%2C+K&amp;rft.au=Williams%2C+RL&amp;rft.au=Condliffe%2C+A&amp;rft.au=Nejentsev%2C+S&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3930011&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APASLI+disease\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-OMIM-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-OMIM_3-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.omim.org/entry/602839\">\"OMIM: PHOSPHATIDYLINOSITOL 3-KINASE, CATALYTIC, DELTA; PIK3CD\"</a><span class=\"reference-accessdate\">. Retrieved 2014</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=OMIM%3A+PHOSPHATIDYLINOSITOL+3-KINASE%2C+CATALYTIC%2C+DELTA%3B+PIK3CD&amp;rft_id=http%3A%2F%2Fwww.omim.org%2Fentry%2F602839&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APASLI+disease\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span> <span style=\"font-size:100%\" class=\"error citation-comment\">Check date values in: <code style=\"color:inherit; border:inherit; padding:inherit;\">&#124;accessdate=</code> (<a href=\"/wiki/Help:CS1_errors#bad_date\" title=\"Help:CS1 errors\">help</a>)</span></span>\n</li>\n<li id=\"cite_note-Seki_1997-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Seki_1997_4-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Seki N; Nimura Y; Ohira M; Saito T; Ichimiya S; Nomura N; Nakagawara A (1997). \"Identification and chromosome assignment of a human gene encoding a novel phosphatidylinositol-3 kinase\". <i>DNA Res</i>. <b>4</b>: 355\u2013358. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1093/dnares/4.5.355\">10.1093/dnares/4.5.355</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9455486\">9455486</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=DNA+Res.&amp;rft.atitle=Identification+and+chromosome+assignment+of+a+human+gene+encoding+a+novel+phosphatidylinositol-3+kinase&amp;rft.volume=4&amp;rft.pages=355-358&amp;rft.date=1997&amp;rft_id=info%3Adoi%2F10.1093%2Fdnares%2F4.5.355&amp;rft_id=info%3Apmid%2F9455486&amp;rft.au=Seki+N&amp;rft.au=Nimura+Y&amp;rft.au=Ohira+M&amp;rft.au=Saito+T&amp;rft.au=Ichimiya+S&amp;rft.au=Nomura+N&amp;rft.au=Nakagawara+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APASLI+disease\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-5\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Lucas, Carrie L.; Zhang, Yu; Venida, Anthony; Wang, Ying; Hughes, Jason; McElwee, Joshua; Butrick, Morgan; Matthews, Helen; Price, Susan; Biancalana, Matthew; Wang, Xiaochuan; Richards, Michael; Pozos, Tamara; Barlan, Isil; Ozen, Ahmet; Rao, Koneti; Su, Helen; Lenardo, Michael (2014). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4267241\">\"Heterozygous splice mutation in PIK3R1 causes human immunodeficiency with lymphoproliferation due to dominant activation of PI3K\"</a>. <i>Journal of Experimental Medicine</i>. <b>211</b> (13): 2537\u20132547. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1084/jem.20141759\">10.1084/jem.20141759</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4267241\">4267241</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25488983\">25488983</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Experimental+Medicine&amp;rft.atitle=Heterozygous+splice+mutation+in+PIK3R1+causes+human+immunodeficiency+with+lymphoproliferation+due+to+dominant+activation+of+PI3K&amp;rft.volume=211&amp;rft.issue=13&amp;rft.pages=2537-2547&amp;rft.date=2014&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4267241&amp;rft_id=info%3Apmid%2F25488983&amp;rft_id=info%3Adoi%2F10.1084%2Fjem.20141759&amp;rft.aulast=Lucas&amp;rft.aufirst=Carrie+L.&amp;rft.au=Zhang%2C+Yu&amp;rft.au=Venida%2C+Anthony&amp;rft.au=Wang%2C+Ying&amp;rft.au=Hughes%2C+Jason&amp;rft.au=McElwee%2C+Joshua&amp;rft.au=Butrick%2C+Morgan&amp;rft.au=Matthews%2C+Helen&amp;rft.au=Price%2C+Susan&amp;rft.au=Biancalana%2C+Matthew&amp;rft.au=Wang%2C+Xiaochuan&amp;rft.au=Richards%2C+Michael&amp;rft.au=Pozos%2C+Tamara&amp;rft.au=Barlan%2C+Isil&amp;rft.au=Ozen%2C+Ahmet&amp;rft.au=Rao%2C+Koneti&amp;rft.au=Su%2C+Helen&amp;rft.au=Lenardo%2C+Michael&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4267241&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APASLI+disease\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-6\">^</a></b></span> <span class=\"reference-text\">Clinicaltrials.gov, study ID: NCT00246857 and NCT00001467</span>\n</li>\n</ol></div>\n\n<!-- \nNewPP limit report\nParsed by mw2135\nCached time: 20180922022228\nCache expiry: 86400\nDynamic content: true\nCPU time usage: 0.436 seconds\nReal time usage: 0.535 seconds\nPreprocessor visited node count: 946/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 23716/2097152 bytes\nTemplate argument size: 227/2097152 bytes\nHighest expansion depth: 9/40\nExpensive parser function count: 1/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 14871/5000000 bytes\nNumber of Wikibase entities loaded: 1/400\nLua time usage: 0.207/10.000 seconds\nLua memory usage: 3.34 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  407.676      1 -total\n 39.69%  161.788      1 Template:Infobox_disease\n 34.36%  140.091      4 Template:Cite_journal\n 29.11%  118.667      1 Template:Infobox\n 19.04%   77.625      1 Template:Orphan\n 13.65%   55.668      1 Template:Ambox\n  3.64%   14.844      1 Template:Comma_separated_entries\n  2.12%    8.661      1 Template:Cite_web\n  1.76%    7.188      2 Template:Main_other\n  0.85%    3.456      1 Template:Monthyear-1\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:42008669-0!canonical and timestamp 20180922022227 and revision id 841412906\n -->\n</div>"},"langlinks":[],"categories":[{"sortkey":"","hidden":"","*":"CS1_errors:_dates"},{"sortkey":"","hidden":"","*":"Orphaned_articles_from_February_2014"},{"sortkey":"","hidden":"","*":"All_orphaned_articles"},{"sortkey":"","hidden":"","*":"Infobox_medical_condition"},{"sortkey":"","*":"Genetic_diseases_and_disorders"}],"links":[{"ns":14,"exists":"","*":"Category:Orphaned articles from February 2014"},{"ns":0,"exists":"","*":"Activated PI3K Delta Syndrome"},{"ns":0,"exists":"","*":"Adaptive immunity"},{"ns":0,"exists":"","*":"Amino acids"},{"ns":0,"exists":"","*":"Autosomal dominant"},{"ns":0,"exists":"","*":"Catalytic"},{"ns":0,"exists":"","*":"Cell membrane"},{"ns":0,"exists":"","*":"Cell signaling"},{"ns":0,"exists":"","*":"Cell surface receptors"},{"ns":0,"exists":"","*":"Chromosome 1"},{"ns":0,"exists":"","*":"Cytomegalovirus"},{"ns":0,"exists":"","*":"Cytopenias"},{"ns":0,"exists":"","*":"De novo mutation"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Enzymes"},{"ns":0,"exists":"","*":"Epstein-Barr virus"},{"ns":0,"exists":"","*":"Expressivity (genetics)"},{"ns":0,"exists":"","*":"GTPase"},{"ns":0,"exists":"","*":"Genetic disorder"},{"ns":0,"exists":"","*":"Hepatosplenomegaly"},{"ns":0,"exists":"","*":"IgA"},{"ns":0,"exists":"","*":"IgM"},{"ns":0,"exists":"","*":"Immune system"},{"ns":0,"exists":"","*":"Immunodeficiency"},{"ns":0,"exists":"","*":"Immunoglobulin"},{"ns":0,"exists":"","*":"Infections"},{"ns":0,"exists":"","*":"Leukocytes"},{"ns":0,"exists":"","*":"Lymphadenopathy"},{"ns":0,"exists":"","*":"Lymphoma"},{"ns":0,"exists":"","*":"Lymphoproliferative disorders"},{"ns":0,"exists":"","*":"MTOR pathway"},{"ns":0,"exists":"","*":"Mutation"},{"ns":0,"exists":"","*":"Mutations"},{"ns":0,"exists":"","*":"National Institute of Allergy and Infectious Diseases"},{"ns":0,"exists":"","*":"National Institutes of Health"},{"ns":0,"exists":"","*":"OMIM"},{"ns":0,"exists":"","*":"P110\u03b4"},{"ns":0,"exists":"","*":"P85\u03b1"},{"ns":0,"exists":"","*":"PIK3CD"},{"ns":0,"exists":"","*":"PIK3R1"},{"ns":0,"exists":"","*":"Pathogens"},{"ns":0,"exists":"","*":"Phosphatidylinositol"},{"ns":0,"exists":"","*":"Phosphorylate"},{"ns":0,"exists":"","*":"Protein domain"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Random assortment"},{"ns":0,"exists":"","*":"Rapamycin"},{"ns":0,"exists":"","*":"Regulatory"},{"ns":0,"exists":"","*":"Respiratory system"},{"ns":0,"exists":"","*":"Senescent"},{"ns":0,"exists":"","*":"Splice site"},{"ns":0,"exists":"","*":"T cells"},{"ns":0,"exists":"","*":"Telomeres"},{"ns":0,"exists":"","*":"Transitional B cells"},{"ns":0,"exists":"","*":"University of Cambridge"},{"ns":0,"exists":"","*":"Viremia"},{"ns":4,"exists":"","*":"Wikipedia:Orphan"},{"ns":12,"exists":"","*":"Help:CS1 errors"},{"ns":12,"exists":"","*":"Help:Link"}],"templates":[{"ns":10,"exists":"","*":"Template:Orphan"},{"ns":10,"exists":"","*":"Template:Ambox"},{"ns":10,"exists":"","*":"Template:Monthyear"},{"ns":10,"exists":"","*":"Template:Monthyear-1"},{"ns":10,"exists":"","*":"Template:PAGENAMEU"},{"ns":10,"exists":"","*":"Template:Infobox disease"},{"ns":10,"exists":"","*":"Template:Infobox medical condition"},{"ns":10,"exists":"","*":"Template:Infobox"},{"ns":10,"exists":"","*":"Template:Comma separated entries"},{"ns":10,"exists":"","*":"Template:Template other"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Message box"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Message box/configuration"},{"ns":828,"exists":"","*":"Module:Category handler"},{"ns":828,"exists":"","*":"Module:Category handler/data"},{"ns":828,"exists":"","*":"Module:Category handler/config"},{"ns":828,"exists":"","*":"Module:Category handler/shared"},{"ns":828,"exists":"","*":"Module:Category handler/blacklist"},{"ns":828,"exists":"","*":"Module:Namespace detect/data"},{"ns":828,"exists":"","*":"Module:Namespace detect/config"},{"ns":828,"exists":"","*":"Module:Infobox"},{"ns":828,"exists":"","*":"Module:Navbar"},{"ns":828,"exists":"","*":"Module:InfoboxImage"},{"ns":828,"exists":"","*":"Module:Separated entries"},{"ns":828,"exists":"","*":"Module:TableTools"},{"ns":828,"exists":"","*":"Module:Wikidata"},{"ns":828,"exists":"","*":"Module:I18n"},{"ns":828,"*":"Module:Infobox/i18n"},{"ns":828,"exists":"","*":"Module:Wikidata/i18n"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"},{"ns":828,"exists":"","*":"Module:Math"},{"ns":828,"exists":"","*":"Module:ParameterCount"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"}],"images":["Lock-green.svg","Wiki_letter_w.svg","Proposed_model_for_the_effects_of_activating_substitutions_in_p110\u03b4.png","Protein_domains_of_p110delta.png"],"externallinks":["//www.ncbi.nlm.nih.gov/pmc/articles/PMC4209962","//doi.org/10.1038/ni.2771","//www.ncbi.nlm.nih.gov/pubmed/24165795","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3930011","//doi.org/10.1126/science.1243292","//www.ncbi.nlm.nih.gov/pubmed/24136356","http://www.omim.org/entry/602839","//doi.org/10.1093/dnares/4.5.355","//www.ncbi.nlm.nih.gov/pubmed/9455486","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4267241","//doi.org/10.1084/jem.20141759","//www.ncbi.nlm.nih.gov/pubmed/25488983","//edwardbetts.com/find_link?q=PASLI_disease","https://omim.org/entry/615513,","http://www.merriam-webster.com/medical/sinopulmonary"],"sections":[{"toclevel":1,"level":"2","line":"Signs and symptoms","number":"1","index":"1","fromtitle":"PASLI_disease","byteoffset":2616,"anchor":"Signs_and_symptoms"},{"toclevel":1,"level":"2","line":"Genetics","number":"2","index":"2","fromtitle":"PASLI_disease","byteoffset":3740,"anchor":"Genetics"},{"toclevel":2,"level":"3","line":"Inheritance","number":"2.1","index":"3","fromtitle":"PASLI_disease","byteoffset":7293,"anchor":"Inheritance"},{"toclevel":1,"level":"2","line":"Diagnosis","number":"3","index":"4","fromtitle":"PASLI_disease","byteoffset":8630,"anchor":"Diagnosis"},{"toclevel":1,"level":"2","line":"Treatment","number":"4","index":"5","fromtitle":"PASLI_disease","byteoffset":9079,"anchor":"Treatment"},{"toclevel":1,"level":"2","line":"References","number":"5","index":"6","fromtitle":"PASLI_disease","byteoffset":9960,"anchor":"References"}],"parsewarnings":[],"displaytitle":"PASLI disease","iwlinks":[{"prefix":"d","url":"https://www.wikidata.org/wiki/Q17152451","*":"d:Q17152451"}],"properties":[{"name":"wikibase_item","*":"Q17152451"}]}}